Cargando…
The role of plasminogen activator inhibitor-1 in gastric mucosal protection
Gastric mucosal health is maintained in response to potentially damaging luminal factors. Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) disrupt protective mechanisms leading to bleeding and ulceration. The plasminogen activator system has been implicated in fibrinolysis following gastric...
Autores principales: | Kenny, Susan, Steele, Islay, Lyons, Suzanne, Moore, Andrew R., Murugesan, Senthil V., Tiszlavicz, Laszlo, Dimaline, Rod, Pritchard, D. Mark, Varro, Andrea, Dockray, Graham J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652002/ https://www.ncbi.nlm.nih.gov/pubmed/23494120 http://dx.doi.org/10.1152/ajpgi.00017.2013 |
Ejemplares similares
-
Gastric Expression of Plasminogen Activator Inhibitor (PAI)-1 Is Associated with Hyperphagia and Obesity in Mice
por: Kenny, Susan, et al.
Publicado: (2013) -
Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells
por: Kenny, Susan, et al.
Publicado: (2008) -
Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
por: Veysey-Smith, Reuben, et al.
Publicado: (2021) -
Cytokine gene expression in mucosal T lymphocyte populations
por: O'Keeffe, J., et al.
Publicado: (1997) -
Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption
por: Balesaria, Sara, et al.
Publicado: (2009)